Page 22 - GPD-2-2

Gene & Protein in Disease MOR in cancer

with improved activity toward the gefitinib-resistant 81. Heaney A, Buggy DJ, 2012, Can anaesthetic and analgesic
non-small cell lung cancers (NSCLC). Eur J Med Chem, techniques affect cancer recurrence or metastasis? Br J
133: 329–339. Anaesth, 109 Suppl 1: i17–i28.
https://doi.org/10.1016/j.ejmech.2017.03.083 https://doi.org/10.1093/bja/aes421
71. Ma M, Wang X, Liu N, et al., 2020, Low-dose naltrexone 82. Li Y, Li G, Tao T, et al., 2019, The µ-opioid receptor (MOR)
inhibits colorectal cancer progression and promotes promotes tumor initiation in hepatocellular carcinoma.
apoptosis by increasing M1-type macrophages and Cancer Lett, 453: 1–9.
activating the Bax/Bcl-2/caspase-3/PARP pathway. Int https://doi.org/10.1016/j.canlet.2019.03.038
Immunopharmacol, 83: 106388.
83. Rogers JB, Higa GM, 2022, Spoken and unspoken
https://doi.org/10.1016/j.intimp.2020.106388 matters regarding the use of opioids in cancer. J Pain Res,
72. Cata JP, Uhelski ML, Gorur A, et al., 2002, The µ-opioid 15: 909–924.
receptor in cancer and its role in perineural invasion: https://doi.org/10.2147/JPR.S349107
A short review and new evidence. Adv Biol (Weinh), 6(9):
e2200020. 84. Zylla D, Gourley BL, Vang D, et al., 2013, Opioid requirement,
opioid receptor expression, and clinical outcomes in patients
https://doi.org/10.1002/adbi.202200020 with advanced prostate cancer. Cancer, 119(23): 4103–4110.
73. Scopsi L, Balslev E, Brünner N, et al., 1989, Immunoreactive https://doi.org/10.1002/cncr.28345
opioid peptides in human breast cancer. Am J Pathol, 134(2):
473–479. 85. Lennon FE, Mirzapoiazova T, Mambetsariev B, et al., 2012,
Overexpression of the µ-opioid receptor in human non-small
74. Bortsov AV, Millikan RC, Belfer I, et al., 2012, µ-Opioid cell lung cancer promotes Akt and mTOR activation, tumor
receptor gene A118G polymorphism predicts survival in growth, and metastasis. Anesthesiology, 116(4): 857–867.
patients with breast cancer. Anesthesiology, 116(4): 896–902.
https://doi.org/10.1097/ALN.0b013e31824babe2
https://doi.org/10.1097/ALN.0b013e31824b96a1
86. Liu X, Yang J, Yang C, et al., 2021, Morphine promotes the
75. Cao W, Lee H, Wu W, et al., 2020, Multi-faceted epigenetic malignant biological behavior of non-small cell lung cancer
dysregulation of gene expression promotes esophageal cells through the MOR/Src/mTOR pathway. Cancer Cell Int,
squamous cell carcinoma. Nat Commun, 11(1): 3675. 21(1): 622.
https://doi.org/10.1038/s41467-020-17227-z https://doi.org/10.1186/s12935-021-02334-8
76. Gao P, Mu M, Chen Y, et al., 2021, Corrigendum to “Yes- 87. Lu J, Liu Z, Zhao L, et al., 2013, In vivo and in vitro inhibition
associated protein upregulates filopodia formation to of human liver cancer progress by downregulation of the
promote alveolar epithelial-cell phagocytosis” Immunol. µ-opioid receptor and relevant mechanisms. Oncol Rep,
Lett. 225 (2020) 44-49]. Immunol Lett, 239: 113–115. 30(4): 1731–1738.
https://doi.org/10.1016/j.imlet.2021.03.005 https://doi.org/10.3892/or.2013.2640
77. Lu Z, Xu J, Xu M, et al., 2018, Truncated µ-opioid receptors 88. Belltall A, Mazzinari G, Garrido-Cano I, et al., 2022, Opioid
with 6 transmembrane domains are essential for opioid receptor expression in colorectal cancer: A nested matched
analgesia. Anesth Analg, 126(3): 1050–1057. case-control study. Front Oncol, 12: 801714.
https://doi.org/10.1213/ANE.0000000000002538 https://doi.org/10.3389/fonc.2022.801714
78. Zhang H, 2022, Cancer pain management-new therapies. 89. Haque MR, Barlass U, Armstrong A, et al., 2022, Novel role
Curr Oncol Rep, 24(2): 223–226. of the Mu-opioid receptor in pancreatic cancer: Potential
https://doi.org/10.1007/s11912-021-01166-z link between opioid use and cancer progression. Mol Cell
Biochem, 477(5): 1339–1345.
79. Santoni A, Santoni M, Arcuri E, 2022, Chronic cancer
pain: Opioids within tumor microenvironment affect https://doi.org/10.1007/s11010-022-04377-5
neuroinflammation, tumor and pain evolution. Cancers 90. Li T, Kang G, Wang T, et al., 2018, Tumor angiogenesis and
(Basel), 14(9): 2253. anti-angiogenic gene therapy for cancer. Oncol Lett, 16(1):
https://doi.org/10.3390/cancers14092253 687–702.
80. Scroope CA, Singleton Z, Hollmann MW, et al., 2021, Opioid https://doi.org/10.3892/ol.2018.8733
receptor-mediated and non-opioid receptor-mediated roles 91. Harry JA, Ormiston ML, 2021, Novel pathways for targeting
of opioids in tumour growth and metastasis. Front Oncol, tumor angiogenesis in metastatic breast cancer. Front Oncol,
11: 792290. 11: 772305.
https://doi.org/10.3389/fonc.2021.792290 https://doi.org/10.3389/fonc.2021.772305

Volume 2 Issue 2 (2023) 16 https://doi.org/10.36922/gpd.282